Tag: Alzheimer’s drug rejection in NHS
Alzheimer’s Drug Rejected for Widespread Use in NHS England – What Happens Next?
A groundbreaking Alzheimer's drug called donanemab has been denied widespread use in the NHS in England. The UK's medicines regulator approved the drug, but the National Institute of Health and Care Excellence (NICE) stated...